The paper reports the results of a retrospective observational study assessing adverse events and changes in glucose control (verified with the use of continuous glucose monitoring system) after vaccination for COVID19 in patients with type 2 diabetes.
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) / Dicembrini I., Vitale V., Cosentino C., Cresci B., Pala L., Pieri M., Yannas D., Vannucci M., Zago E., Romani A., Delli Poggi C., Mariani S.L., Scoccimarro D., Cocchetti C., Monami M., Mannucci E.. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - STAMPA. - 59:(2022), pp. 435-438. [10.1007/s00592-021-01837-0]
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)
Dicembrini I.;Cosentino C.;Cresci B.;Pala L.;Yannas D.;Vannucci M.;Zago E.;Delli Poggi C.;Mariani S. L.;Scoccimarro D.;Cocchetti C.;Monami M.;Mannucci E.
2022
Abstract
The paper reports the results of a retrospective observational study assessing adverse events and changes in glucose control (verified with the use of continuous glucose monitoring system) after vaccination for COVID19 in patients with type 2 diabetes.
| File | Dimensione | Formato | |
|---|---|---|---|
|
s00592-021-01837-0.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
459.44 kB
Formato
Adobe PDF
|
459.44 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
